跳至主要内容
临床试验/CTRI/2025/02/081053
CTRI/2025/02/081053尚未招募不适用

A descriptive observational study on prescribing pattern of drugs among outpatients attending department of neurology at Sawai Man Singh Hospital, Jaipur, during 2024-2026.

Harsh Vardhan Bharadwaj1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年2月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400
试验地点
1
主要终点
Average number of drugs per encounter (prescription).

研究概览

简要总结

The purpose of study is to find out the current prescribing pattern of drugs in various neurological disorders by using WHO core prescribing indicators, Anatomical Therapeutic Classification and Defined Daily Dose method. The study will provide an insight into the pattern of prescription writing, drug-drug interactions (if any), self medication and possible areas of improvement in drug prescribing practices.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed cases with Neurological disorders attending the outpatient department of Neurology.
  • Patients who are willing to participate and give written informed consent.
  • Patients aged 18 years and above of either sex.

排除标准

  • Patients who are critically ill, uncooperative patients.
  • Post-surgical patients with neurological diseases/condition.

结局指标

主要结局

Average number of drugs per encounter (prescription).

时间窗: At first encounter only

Percentage of drugs prescribed with the generic name.

时间窗: At first encounter only

Percentage of encounters (prescription) with antibiotics prescribed.

时间窗: At first encounter only

Percentage of encounters (prescription) with injections prescribed.

时间窗: At first encounter only

Percentage of drugs prescribed from National List of Essential Medicines (NLEM 2022).

时间窗: At first encounter only

次要结局

  • Distribution of prescribed drugs according to Anatomic Therapeutic Chemical classification with their calculated Daily Defined Dose.(At first encounter only)
  • Percentage of patients with history of self medication.(At first encounter only)
  • Proportion of prescriptions with potential drug-drug interactions.(At first encounter only)

研究者

发起方
Harsh Vardhan Bharadwaj
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Harsh Vardhan Bharadwaj

Sawai Man Singh Medical College

研究点 (1)

Loading locations...

相似试验